In silico analysis of formononetin compound as a breast anti Cancer

Suryani, Yani (2018) In silico analysis of formononetin compound as a breast anti Cancer. Revista Latinoamericana de Hipertensión, 13 (6). pp. 582-589. ISSN 1856-4550

Preview

Text (Full Text) In Silico Analysis of Formononetin Compound as a Breast Anti Cancer.pdf - Published Version Download (765kB) | Preview

Abstract

For long the relationship between estrogen and cancer has been proved. Formononetin is a phytoestrogen which has been reported to have anticancer effects. Phytoestrogens have the same structure and properties as human estrogen and can interact with ER-α without inducing any cell proliferation. While anticancer properties of Formononetin in prevention of other cancers like prostate and carcinoma colon have been studied, its effects on breast cancer remain unknown. The aim of the present study is to analyse the formononetin compound as a competitor of estrogen in terms of the bond quality with ER-α. The method used in this study was in silico or computation by molecular docking method using PvRx software. The data was also analysed using Discovery Studio software. The results showed that the formononetin compounds have a value of free energy equal to -7.3 kcal/mol, lower than 17-β-Estradiol (natural estrogen) that is -6.4 kcal/mol, but higher than 3 alkylnaphthalene (estrogen synthetic) that is -11.2 kcal/mol. Based on the results, formononetin has a great potential as an estrogen competitor because it has a value of free energy that is lower than the natural estrogen.

Actions (login required)

View Item